Ashley Jaksa

420 total citations
31 papers, 257 citations indexed

About

Ashley Jaksa is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Statistics and Probability. According to data from OpenAlex, Ashley Jaksa has authored 31 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Economics and Econometrics, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Statistics and Probability. Recurrent topics in Ashley Jaksa's work include Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (13 papers) and Economic and Financial Impacts of Cancer (4 papers). Ashley Jaksa is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (13 papers) and Economic and Financial Impacts of Cancer (4 papers). Ashley Jaksa collaborates with scholars based in United States, United Kingdom and Germany. Ashley Jaksa's co-authors include Nicolle M. Gatto, Ulka B. Campbell, Páll Jónsson, Robert F. Reynolds, Hans‐Georg Eichler, Jingping Mo, James J. Wu, Julia Hagen, Bjoern M. Eskofier and Nirosha Mahendraratnam and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Ashley Jaksa

25 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Jaksa United States 7 137 67 64 32 25 31 257
Nirosha Mahendraratnam United States 10 100 0.7× 75 1.1× 34 0.5× 26 0.8× 25 1.0× 17 287
Chiara Whichello United States 9 250 1.8× 141 2.1× 41 0.6× 47 1.5× 11 0.4× 25 432
Bhash Naidoo United Kingdom 10 104 0.8× 81 1.2× 10 0.2× 39 1.2× 10 0.4× 15 238
Edmund Njeru Njagi United Kingdom 10 62 0.5× 28 0.4× 60 0.9× 57 1.8× 4 0.2× 24 370
Nicolás Ballarini Austria 10 36 0.3× 27 0.4× 66 1.0× 15 0.5× 6 0.2× 22 272
Theodor A. Balan Netherlands 5 70 0.5× 22 0.3× 77 1.2× 8 0.3× 3 0.1× 8 240
Richardae Araojo United States 9 47 0.3× 54 0.8× 9 0.1× 78 2.4× 8 0.3× 22 211
Michelle Smerek United States 7 27 0.2× 52 0.8× 18 0.3× 72 2.3× 6 0.2× 13 332
Juan Carlos Rejón-Parrilla United Kingdom 8 102 0.7× 56 0.8× 13 0.2× 25 0.8× 4 0.2× 15 197
Benjamin Gregory Carlisle Canada 10 178 1.3× 80 1.2× 69 1.1× 235 7.3× 6 0.2× 30 488

Countries citing papers authored by Ashley Jaksa

Since Specialization
Citations

This map shows the geographic impact of Ashley Jaksa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Jaksa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Jaksa more than expected).

Fields of papers citing papers by Ashley Jaksa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Jaksa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Jaksa. The network helps show where Ashley Jaksa may publish in the future.

Co-authorship network of co-authors of Ashley Jaksa

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Jaksa. A scholar is included among the top collaborators of Ashley Jaksa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Jaksa. Ashley Jaksa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bykov, Katsiaryna, Ashley Jaksa, Jennifer L. Lund, et al.. (2025). APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety. Value in Health. 28(12). 1849–1856.
2.
Kong, Amanda M., Shamim Khan, J. Isabelle Choi, et al.. (2025). Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2. Journal of Comparative Effectiveness Research. 14(11). e250026–e250026.
3.
Jaksa, Ashley, et al.. (2025). Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies. Value in Health. 28(6). 898–906. 1 indexed citations
4.
5.
Levy, Natalie S., Thomas Jemielita, Shahrul Mt‐Isa, et al.. (2024). Use of transportability methods for real-world evidence generation: a review of current applications. Journal of Comparative Effectiveness Research. 13(11). e240064–e240064. 4 indexed citations
6.
Jaksa, Ashley, et al.. (2023). Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations. Journal of Comparative Effectiveness Research. 12(11). e230125–e230125. 1 indexed citations
7.
Stern, Ariel Dora, Jörg F. Debatin, Julia Hagen, et al.. (2022). Advancing digital health applications: priorities for innovation in real-world evidence generation. The Lancet Digital Health. 4(3). e200–e206. 83 indexed citations
8.
Jaksa, Ashley, Anthony Louder, Laura Díaz‐Martín, et al.. (2022). A Comparison of 7 Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies. Value in Health. 25(12). 1967–1976. 28 indexed citations
9.
10.
Jaksa, Ashley, et al.. (2020). ON3 Comparison of External Control Arm (ECA) Critiques in Regulatory and Health Technology Assessment (HTA) Oncology Submissions. Value in Health. 23. S408–S408. 1 indexed citations
11.
Jaksa, Ashley, et al.. (2018). Health Techonolgy Assessment (HTA) Agencies Consideration of Real World Evidence (RWE). Value in Health. 21. S7–S7. 3 indexed citations
12.
13.
Jaksa, Ashley, et al.. (2015). How influential are Patient and professional group submissions on reimbursement decisions for European Medicines Agency Orphan Drugs?. Value in Health. 18(3). A306–A306. 2 indexed citations
14.
Jaksa, Ashley, et al.. (2015). Do evidence review groups bias nice decisions?. Value in Health. 18(7). A335–A335. 2 indexed citations
15.
Jaksa, Ashley, et al.. (2014). Cadth Recommendations As Predictors For Drug Availability In British Columbia And Ontario. Value in Health. 17(3). A6–A6. 4 indexed citations
16.
Jaksa, Ashley, et al.. (2014). Nice Restrictiveness Compared To the Market Authorization. Value in Health. 17(7). A438–A439. 1 indexed citations
17.
Jaksa, Ashley, et al.. (2013). Agency Agreement In Health Technology Assessment Reimbursement Decisions. Value in Health. 16(3). A3–A3. 1 indexed citations
18.
Jaksa, Ashley, et al.. (2013). Use of Surrogate Outcomes in Health Technology Assessments (HTAs). Value in Health. 16(7). A613–A613. 1 indexed citations
19.
20.
Rubinstein, Ellen B., et al.. (2012). PIH55 Use of PRO Analysis in Health Technology Assessments. Value in Health. 15(4). A201–A201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nirosha Mahendraratnam Breakdown of academic impact, for papers by Chiara Whichello Breakdown of academic impact, for papers by Bhash Naidoo Breakdown of academic impact, for papers by Edmund Njeru Njagi Breakdown of academic impact, for papers by Nicolás Ballarini Breakdown of academic impact, for papers by Theodor A. Balan Breakdown of academic impact, for papers by Richardae Araojo Breakdown of academic impact, for papers by Michelle Smerek Breakdown of academic impact, for papers by Juan Carlos Rejón-Parrilla Breakdown of academic impact, for papers by Benjamin Gregory Carlisle
Rankless by CCL
2026